NCT03509896View on ClinicalTrials.gov

Study of Chinese Newly Diagnosed Participants With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

CompletedOBSERVATIONAL
Enrollment

463

Participants

Timeline

Start Date

November 30, 2017

Primary Completion Date

June 7, 2019

Study Completion Date

September 28, 2019

Conditions
Chronic Myeloid LeukemiaPhiladelphia ChromosomeChronic Myeloid Leukemia in Chronic Phase
Interventions
OTHER

Non-Interventional

Non-Interventional

Trial Locations (1)

300020

Local Institution, Tianjin

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03509896 - Study of Chinese Newly Diagnosed Participants With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP) | Biotech Hunter | Biotech Hunter